Boston Scientific’s embolisation device recall labelled as Class I
The company reported 11 incidents, including seven injuries and two deaths, relating to the Obsidio Conformable Embolic device.
18 April 2024
18 April 2024
The company reported 11 incidents, including seven injuries and two deaths, relating to the Obsidio Conformable Embolic device.
The 18-month research project aims to identify key moments when the condition progresses to enable better treatment plans.
The FDA acceptance means that clients who use X-Therma’s cell preservation tech can include these as part of new drug applications.
The company’s revenue for the quarter increased by 2.2% to $9.96bn.
The observational study will assess the clinical and workflow benefits of using Hyperfine’s Swoop system in detecting amyloid abnormalities in Alzheimer’s patients.
The Tablo haemodialysis system will be made available in 33 states where US Renal Care provides care.
The FF-BMA Application transforms BMA analysis with a completely digital workflow that integrates with Scopio's X100 and X100HT platforms.
Annoviant also raised funds matching the NIH grant to advance development and commercialisation of its TxGuard pulmonary-valved conduit.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.